These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28455233)

  • 1. Example-based illustrations of design, conduct, analysis and result interpretation of multi-regional clinical trials.
    Quan H; Mao X; Tanaka Y; Binkowitz B; Li G; Chen J; Zhang J; Zhao PL; Ouyang SP; Chang M
    Contemp Clin Trials; 2017 Jul; 58():13-22. PubMed ID: 28455233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-regional clinical trial design and consistency assessment of treatment effects.
    Quan H; Mao X; Chen J; Shih WJ; Ouyang SP; Zhang J; Zhao PL; Binkowitz B
    Stat Med; 2014 Jun; 33(13):2191-205. PubMed ID: 24515845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing consistency across all regions in a multi-regional clinical trial.
    Tsou HH; James Hung HM; Chen YM; Huang WS; Chang WJ; Hsiao CF
    Pharm Stat; 2012; 11(4):295-9. PubMed ID: 22504851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional consistency and sample size considerations in a multiregional equivalence trial.
    Wu SC; Xu JF; Zhang XJ; Li ZW; He J
    Pharm Stat; 2020 Nov; 19(6):897-908. PubMed ID: 32716135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empirical shrinkage estimator for consistency assessment of treatment effects in multi-regional clinical trials.
    Quan H; Li M; Shih WJ; Ouyang SP; Chen J; Zhang J; Zhao PL
    Stat Med; 2013 May; 32(10):1691-706. PubMed ID: 22855311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical design of noninferiority multiple region clinical trials to assess global and consistent treatment effects.
    Diao G; Zeng D; Ibrahim JG; Rong A; Lee O; Zhang K; Chen Q
    J Biopharm Stat; 2017; 27(6):933-944. PubMed ID: 28296570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nested group sequential framework for regional evaluation in global drug development program.
    Wang W; Jiang Z; Qiu J; Xia J; Guo X
    J Biopharm Stat; 2017; 27(6):945-962. PubMed ID: 28323515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graphical assessment of consistency in treatment effect among countries in multi-regional clinical trials.
    Chen J; Zheng H; Quan H; Li G; Gallo P; Ouyang SP; Binkowitz B; Ting N; Tanaka Y; Luo X; Ibia E;
    Clin Trials; 2013; 10(6):842-51. PubMed ID: 24013404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials.
    Liu JT; Tsou HH; Gordon Lan KK; Chen CT; Lai YH; Chang WJ; Tzeng CS; Hsiao CF
    Stat Med; 2016 Jun; 35(14):2301-14. PubMed ID: 26833851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unified additional requirement in consideration of regional approval for multiregional clinical trials.
    Teng Z; Chen YF; Chang M
    J Biopharm Stat; 2017; 27(6):903-917. PubMed ID: 28287339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inconsistency and drop-minimum data analysis.
    Chen F; Li G; Lan KK
    Stat Med; 2017 Feb; 36(3):416-425. PubMed ID: 27873342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size allocation in multiregional equivalence studies.
    Liao JJZ; Yu Z; Li Y
    Pharm Stat; 2018 Sep; 17(5):570-577. PubMed ID: 29911346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An empirical Bayes approach to evaluation of results for a specific region in multiregional clinical trials.
    Huang Y; Chang WJ; Hsiao CF
    Pharm Stat; 2013; 12(2):59-64. PubMed ID: 23319408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On evaluation of consistency in multi-regional clinical trials.
    Ying L; Song F; Chow SC; Zeng N; Zheng J; Li X; Henry D; Sethuraman V
    J Biopharm Stat; 2018; 28(5):840-856. PubMed ID: 29182430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian joint models for multi-regional clinical trials.
    Bean NW; Ibrahim JG; Psioda MA
    Biostatistics; 2024 Jul; 25(3):852-866. PubMed ID: 37669215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian approach to evaluating regional treatment effect in a multiregional trial.
    Chen YH; Wu YC; Wang M
    J Biopharm Stat; 2009 Sep; 19(5):900-15. PubMed ID: 20183451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A consistency approach to evaluation of bridging studies and multi-regional trials.
    Tsou HH; Chien TY; Liu JP; Hsiao CF
    Stat Med; 2011 Jul; 30(17):2171-86. PubMed ID: 21590701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case study of the effect of covariate adjustment in a sequential survival clinical trial.
    Todd S; Sahdra M
    J Biopharm Stat; 2001 Nov; 11(4):297-311. PubMed ID: 12018781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of multiregional trials with heterogeneous treatment effect across regions.
    Chen CT; Hung HM; Hsiao CF
    J Biopharm Stat; 2012 Sep; 22(5):1037-50. PubMed ID: 22946948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design issues and treatment effect modeling in multi-regional schizophrenia trials.
    Chen YF; Wang SJ; Khin NA; Hung HM; Laughren TP
    Pharm Stat; 2010; 9(3):217-29. PubMed ID: 20872622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.